Summary
In healthy men insulin-induced hypoglycemia offers the opportunity to examine under nearly physiologic conditions the potential effects of human atrial natriuretic peptide (human ANF- (99–126), hANP) on catecholamine- or vasopressin-related events. Thus, evidence is presented that 100 μg hANP given as an i.v. bolus injection does not inhibit the counter-regulatory increase in epinephrine and norepinephrine concentrations in plasma in response to decreased blood glucose levels. However, hANP is found to inhibit, by direct or indirect mechanisms, the epinephrine-mediated increase in heart rate and systolic blood pressure and to antagonize the action predominantly of norepinephrine on diastolic blood pressure. Whereas the sodium-retaining effect of insulin-induced hypoglycemia is completely reversed by hANP, its anti-diuretic effect is only partially suppressed. It appears likely that under physiologic conditions the antagonizing action of hANP on the renal response to vasopressin is more prominent than its potential capacity to inhibit vasopressin secretion. Moreover, hANP is found to increase the effectiveness of exogenous insulin. This is probably predominantly due to its inhibiting effect on the hepatic insulin break-down.
In endocrinological research, insulin-induced hypoglycemia is a well-defined and thoroughly studied experimental model for investigating the effects of metabolic stress on hormonal systems. The concomitant stimulation by insulin-induced hypoglycemia of the release of vasopressin, epinephrine and norepinephrine is part of its most prominent hormonal characteristics (1,2). Therefore, insulin-induced hypoglycemia offers the unique opportunity to examine in healthy man under nearly physiological conditions whether human atrial natriuretic peptide (human ANF-(99–126), hANP) is capable of influencing the release or the effects of raised concentrations of these hormones on renal and cardiovascular indexes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rosak, C. (1987) Regulation der Hypoglykämie. Fortschr Med 105: 230–232
Baylis, P-H., Zerbe, R.L., Robertson, G.L. (1981) Arginine vasopressin response to insulin-induced hypoglycemia. J Clin Endocr Metab 53: 935–940
Da Prada, M., Zürcher, G. (1976) Simultaneous radio enzymatic determination of plasma and tissue adrenalin, noradrenalin and dopamine within the femtomole range. Life Sci 19: 1161–1174
Jungmann, E., Höll, E., Konzok, C., Schirmer, U., Walter-Schräder, M.C., Althoff, P.H., Schöffling, K. (1988) Zur Wirkung des humanen atrialen natriuretischen Peptides auf Insulinspiegel und Insulinsekretion. Med Klin 83: 325–326
Jungmann, E., Walter-Schrader, M.C., Haak, T., Fassbinder, W., Rosak, M.C., Althoff, P.H., Schöffling, K. (1988) Impaired renal responsiveness to human atrial natriuretic peptide (hANP) in normotensive patients with Type 1 diabetes mellitus. Klin Wochenschr 66: 527–532
Kuchel, O., Debinski, W., Racz, K., Buu, N.T., De Léan, A., Garcia, R., Cantin, M., Genest, J. (1987) Atrial natriuretic factor is an inhibitory modulator of peripheral sympathoadrenomedullary activity. In: Brenner, B.M., Laragh, J.H. (eds.) Biologically active atrial peptides. Raven Press, New York
Holtz, J., Sommer, O., Bassenge, E. (1987) Inhibition of sympathoadrenal activity by atrial natriuretic factor in dogs. Hypertension 9: 350–354.
Nicholls, M.G., Richards, A.M. (1987) Human studies with atrial natriuretic factor. Endocrinology and Metabolism Clinics of North America 16: 199–223
Liang, C.S., Doherty, J.U., Faillace, R., Maekawa, K., Arnold, S., Gavras, H., Hood, W.B. (1982) Insulin infusion in conscious dogs. J Clin Invest 69: 1321–1336
Winquist, R.J. (1987) Pharmacologic effects of atrial natriuretic peptide. Endocrinology and Metabolism Clinics of North America 16: 163–182
Vierhapper, H., Waldhäusl, W. (1987) Effects of human atrial natriuretic peptide on dDAVP-induced antidiuresis in man. Acta endocrinol (suppl 283): 15
Samson, W.K. (1987) Atrial natriuretic factor and the central nervous system. Endocrinology and Metabolism Clinics of North America 16: 145–162
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1989 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Jungmann, E., Konzok, C., Höll, E., Fassbinder, W., Schöffling, K. (1989). The effect of human atrial natriuretic peptide on renal and cardiovascular responses to insulin-induced hypoglycemia in healthy man. In: Forssmann, WG., Scheuermann, D.W., Alt, J. (eds) Functional Morphology of the Endocrine Heart. Steinkopff. https://doi.org/10.1007/978-3-642-72432-9_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-72432-9_26
Publisher Name: Steinkopff
Print ISBN: 978-3-642-72434-3
Online ISBN: 978-3-642-72432-9
eBook Packages: Springer Book Archive